SOBR Safe, Inc. — SEC Form D Filing

SOBR Safe, Inc. filed an SEC Form D on January 12, 2026, reporting $2.00M raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
January 12, 2026
Amount reported
$2.00M
Round stage
Series B+
Industry
Health Technology
Headquarters
Boulder, CO, USA
Website
https://sobrsafe.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Traditional alcohol detection methods like breathalyzers, blood, or urine tests are invasive, time-consuming, and can be easily circumvented, making continuous and discreet alcohol monitoring difficult for various applications such as recovery programs, judicial oversight, and workplace safety.

Solution

SOBRsafe provides non-invasive, real-time transdermal (touch-based) alcohol detection through wearable sensors and stationary screening devices, enabling discreet and continuous monitoring, reporting, and verification suitable for individuals, behavioral health providers, commercial fleets, and judicial systems.

Why now

There is an increasing demand for discreet, continuous, and non-invasive alcohol monitoring solutions driven by advancements in wearable technology, a growing emphasis on behavioral health and recovery support, and the necessity for enhanced safety protocols in various sectors.

Verdict

Investors backed this because the immediate and clear replacement play offered a tangible cost-saving and discreet monitoring alternative to existing cumbersome methods. This cleared because of the identified pain in specific B2B sectors, not because the underlying technology was a proven breakthrough. The implicit bet was on rapid adoption within identified enterprise markets willing to pay a premium for convenience and reduced friction, but the upside was limited by the significant hurdle of regulatory approval and the potential for new, more accurate alternatives to emerge.

Source: SEC EDGAR Form D filing